Patent ID: 9192576
Filing Date: 2015-11-24
Classification: A61K,A61P

Abstract:
1. A dosage form comprising bromocriptine mesylate and one or more excipients in the form of an oral tablet; wherein the bromocriptine mesylate is present in an amount that provides a dose of at least about 0.8 mg of bromocriptine per said oral tablet; and wherein the oral tablet provides for absorption of a substantial amount of bromocriptine through the gastric and/or intestinal mucosa when administered to a subject; wherein the bromocriptine mesylate has a particle size distribution with a span of about 2 or lower; and wherein the oral tablet has a dissolution profile wherein at least about 80% of the bromocriptine mesylate has been released at about 30 minutes, when tested in USP Apparatus Type 2 Paddle Method at 50 rpm in 500 mL of 0.1 N hydrochloric acid at about 37° C.